MedTrace Logo

Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer

NCT00003006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501

Last updated 2016-06-29

No results posted yet for this study

Summary

RATIONALE: Detecting very early metastases in bone marrow and/or lymph nodes may help doctors plan better treatment for non-small cell lung cancer.

PURPOSE: Clinical trial to detect the presence of metastatic cancer in patients with stage I non-small cell lung cancer that has not been previously treated.

Conditions

Interventions

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

immunohistochemistry staining method

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Michael Maddaus, MD · Masonic Cancer Center, University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-05-31
Primary Completion
2002-03-31
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003006 on ClinicalTrials.gov